0102030405
Sitagliptin Intermediates CAS NO 486460-00-8 Pharmaceutical Intermediates
02
introduce
As a leading integrated chemical company, we are committed to providing high-quality Sitagliptin CAS 654671-78-0 intermediates that meet the stringent requirements of the pharmaceutical industry. Our state-of-the-art production facilities and experienced team ensure that we deliver products that meet the highest quality standards. We understand the importance of a reliable supply chain and provide flexible solutions based on your specific needs.
02
Physical and chemical properties
Sitagliptin CAS 654671-78-0 intermediates are important components in the synthesis of sitagliptin, a DPP-4 inhibitor that has attracted much attention for its efficacy in the treatment of type 2 diabetes.
- Molecular formula: C15H18F3NO4
- Molecular weight: 333.31 g/mol
- Appearance: White to off-white crystalline powder
- Melting point: approx. 150-155 °C
- Solubility: Soluble in water and organic solvents, easy to formulate and process.
The unique structure of the sitagliptin intermediate characterizes its DPP-4 inhibitory activity, which enhances its effectiveness in controlling blood glucose levels, making it an important component of diabetes management.
Adding Sitagliptin CAS 654671-78-0 intermediate to drug formulation has the following advantages:
1. Effective Blood Sugar Control: Sitagliptin is known for its ability to effectively lower blood sugar levels, making it a top choice for patients with type 2 diabetes.
2. Improve patient compliance: The oral formulation of sitagliptin is convenient for patients to take and helps them adhere to the treatment plan.
3. Minimal side effects: Compared with other diabetes drugs, sitagliptin has a good safety profile and fewer gastrointestinal side effects.
4. Multiple Applications: These intermediates can be used in various formulations, including combination therapies, enhancing their utility in diabetes management.
Sitagliptin CAS 654671-78-0 intermediates are mainly used in the pharmaceutical industry to synthesize Sitagliptin, which is used to treat type 2 diabetes. Its unique properties make it suitable for a variety of applications, including:
- Synthesis of Sitagliptin: The intermediate is a key building block for the production of sitagliptin, which helps in the development of effective diabetes treatments.
- Research and Development: Pharmaceutical researchers utilize sitagliptin intermediates to develop new formulations and therapeutic strategies, particularly in the areas of endocrinology and metabolic disorders.
- Formulation Development: Intermediates can be incorporated into various dosage forms, including tablets and oral solutions, to improve patient compliance and therapeutic efficacy.
In conclusion, Sitagliptin CAS 654671-78-0 intermediates are key building blocks for the pharmaceutical industry, offering numerous advantages for drug development and synthesis. With our expertise and commitment to quality, we are a trusted partner for all your chemistry needs. Contact us today to learn more about our products and how we can support your business in the growing pharmaceutical sector.